In RA patients, the IL-6 molecule is overexpressed in inflamed synovial tissues, where it effects the functions of lymphocytes (T and B), macrophages and osteoclasts by binding to IL-6R (Smolen et al., 2008). Here, IL6 is linked to rheumatoid arthritis.